Therapeutic potential of extracellular vesicle-associated long noncoding RNA

Louis J. Born, John W. Harmon, Steven M. Jay

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Both extracellular vesicles (EVs) and long noncoding RNAs (lncRNAs) have been increasingly investigated as biomarkers, pathophysiological mediators, and potential therapeutics. While these two entities have often been studied separately, there are increasing reports of EV-associated lncRNA activity in processes such as oncogenesis as well as tissue repair and regeneration. Given the powerful nature and emerging translational impact of other noncoding RNAs such as microRNA (miRNA) and small interfering RNA, lncRNA therapeutics may represent a new frontier. While EVs are natural vehicles that transport and protect lncRNAs physiologically, they can also be engineered for enhanced cargo loading and therapeutic properties. In this review, we will summarize the activity of lncRNAs relevant to both tissue repair and cancer treatment and discuss the role of EVs in enabling the potential of lncRNA therapeutics.

Original languageEnglish (US)
Article numbere10172
JournalBioengineering and Translational Medicine
Issue number3
StatePublished - Sep 1 2020


  • exosomes
  • extracellular vesicles
  • lncRNA
  • microparticles
  • microvesicles

ASJC Scopus subject areas

  • Biotechnology
  • Biomedical Engineering
  • Pharmaceutical Science


Dive into the research topics of 'Therapeutic potential of extracellular vesicle-associated long noncoding RNA'. Together they form a unique fingerprint.

Cite this